Separately, OGT obtains rights to NimbleGen’s DNA microarrays.

NimbleGen Systems licensed Oxford Gene Technology’s (OGT) Southern array patents covering the manufacture and commercialization of oligonucleotide arrays. In addition, NimbleGen will be able to make and sell OGT-designed arrays, and OGT will obtain DNA microarrays from NimbleGen, under a supply agreement between the two firms.

“Successful discussions with NimbleGen have concluded with the granting of this license thus enabling NimbleGen to deliver their microarray products and services worldwide and adding to OGT’s growing portfolio of North American licensees,” says Sue Sutton, vp licensing North America at OGT.

Previous articleAlkermes To Be Exclusive Supplier for Lilly’s AIR® Inhaled Insulin System
Next articleCatalyst and Wyeth Ink Agreements Worth Up To $100M